-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Mereo BioPharma Group to Underweight

Benzinga·08/19/2026 12:39:10
Listen to the news
JP Morgan analyst Priyanka Grover downgrades Mereo BioPharma Group (NASDAQ:MREO) from Neutral to Underweight.